Sarepta Therapeutics (SRPT) P/E (2011 - 2026)
Sarepta Therapeutics (SRPT) P/E from Mar 31, 2011 to Jul 21, 2026. The TTM Sarepta Therapeutics (SRPT) P/E is 4.49. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Sarepta Therapeutics (SRPT)
| Year | P/E | Change |
|---|---|---|
| 2026 | 4.49 | -185.25% |
| 2025 | -5.27 | -107.18% |
| 2024 | 73.37 | -669.50% |
| 2023 | -12.88 | -18.65% |
| 2022 | -15.84 | -9.97% |
| 2021 | -17.59 | -27.50% |
| 2020 | -24.26 | +80.19% |
| 2019 | -13.47 | -34.42% |
| 2018 | -20.53 | -27.55% |
| 2017 | -28.34 | +423.72% |
| 2016 | -5.41 | -27.74% |
| 2015 | -7.49 | +73.75% |
| 2014 | -4.31 | -31.01% |
| 2013 | -6.25 | +7.12% |
| 2012 | -5.83 | -96.95% |
| 2011 | -191.30 | N/A |
Comparison Sarepta Therapeutics (SRPT) P/E with competitors
Sarepta Therapeutics (SRPT) P/E is 4.49.